市場調查報告書
商品編碼
1519380
2024-2032 年按產品、細胞類型、技術、應用、最終用戶和地區分類的細胞分離技術市場報告Cell Separation Technologies Market Report by Product, Cell Type, Technology, Application, End User, and Region 2024-2032 |
IMARC Group年,全球細胞分離技術市場規模達104億美元。製藥和生物技術領域擴大採用細胞分離技術、對個人化醫療的需求不斷成長以及行業持續的技術進步是推動市場的一些關鍵因素。
細胞分離技術或細胞隔離技術是指用於從異質細胞混合物中分離特定細胞的一系列方法和技術。一些標準技術包括微流體細胞分選、螢光活化細胞分選 (FACS)、免疫原性細胞分離、磁活化細胞分選 (MACS) 和密度梯度配置。細胞分離技術有助於分離罕見的腫瘤細胞或幹細胞,用於進一步分析和治療目的。因此,它們被廣泛用於醫療保健和生物技術行業的研究、臨床和工業應用,例如疾病診斷、藥物發現和生物加工。除此之外,細胞分離技術對於研究細胞異質性以了解疾病機制和開發個人化藥物至關重要。
整個製藥業擴大使用細胞分離技術來增強藥物發現和開發程序,這是推動市場成長的主要因素。與此一致的是,癌症、後天免疫缺乏症候群(愛滋病)和囊性纖維化等多種慢性和傳染病的日益普及正在推動市場成長。此外,對個人化和再生醫學的需求不斷成長,推動了對高度特異性細胞分離技術的需求,這些技術可以分離特定的細胞類型以進行標靶治療。除此之外,細胞分離技術在生產多種疾病疫苗中的廣泛應用,包括人類乳突病毒(HPV)、流感和輪狀病毒,正在為市場創造良好的前景。除此之外,在蓬勃發展的生物技術領域對研發(R&D)計劃的廣泛投資,以開發新型細胞療法和治療方法,也促進了市場的成長。同時,對幹細胞研究的高度關注、體外診斷需求的激增以及各國政府為改善醫療基礎設施而採取的眾多有利舉措的實施都有助於市場擴張。此外,細胞分離技術(例如微流體、晶片實驗室和微陣列技術)的不斷進步,為市場帶來了有利可圖的成長機會。此外,先進的分離工具的出現可以連續檢查核酸、染色質、蛋白質和其他複雜細胞,這正在成為另一個重要的生長誘導因素。
The global cell separation technologies market size reached US$ 10.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.9 Billion by 2032, exhibiting a growth rate (CAGR) of 13.7% during 2024-2032. The rising adoption of cell separation technologies across the pharmaceutical and biotechnology sectors, the growing demand for personalized medicine, and ongoing technological advancements in the industry represent some of the key factors driving the market.
Cell separation technologies, or cell isolation technologies, refer to a range of methods and techniques used to isolate specific cells from a heterogeneous mixture of cells. Some of the standard techniques include microfluidic cell sorting, fluorescence-activated cell sorting (FACS), immunogenicity cell isolation, magnetic-activated cell sorting (MACS), and density gradient configuration. Cell separation technologies help isolate rare tumor cells or stem cells for further analysis and therapeutic purposes. As a result, they are used across the healthcare and biotechnology industries for research, clinical, and industrial applications, such as disease diagnosis, drug discovery, and bioprocessing. In addition to this, cell separation technologies are essential for studying cellular heterogeneity to understand disease mechanisms and develop personalized medicines.
The increasing use of cell separation technologies across the pharmaceutical industry to enhance drug discovery and development procedures represents the primary factor driving the market growth. In line with this, the growing prevalence of numerous chronic and infectious diseases, such as cancer, acquired immune deficiency syndrome (AIDS), and cystic fibrosis, is propelling the market growth. Moreover, the increasing demand for personalized and regenerative medicines is fueling the need for highly specific cell separation technologies that can isolate specific cell types for targeted therapy. Besides this, the widespread utilization of cell separation technologies in manufacturing vaccines for various diseases, including human papillomavirus (HPV), influenza, and rotavirus, is creating a favorable outlook for the market. In addition to this, extensive investments in research and development (R&D) initiatives in the flourishing biotechnology sector for developing novel cell-based treatments and therapies are contributing to the market growth. Concurrent with this, an intensive focus on stem cell research, the surging demand for in vitro diagnostics, and the implementation of numerous favorable initiatives undertaken by governments of various countries to improve healthcare infrastructure are aiding in market expansion. Furthermore, ongoing technological advancements in cell separation technologies, such as microfluidics, lab-on-a-chip, and microarray technologies, are presenting remunerative growth opportunities for the market. Furthermore, the advent of advanced isolation tools that allows continuous examination of nucleic acids, chromatin, proteins, and other complex cells is acting as another significant growth-inducing factor.
IMARC Group provides an analysis of the key trends in each sub-segment of the global cell separation technologies market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, cell type, technology, application and end user.
Instruments
Consumables
The report has provided a detailed breakup and analysis of the cell separation technologies market based on the product. This includes instruments and consumables. According to the report, consumables represented the largest segment.
Human Cells
Animal Cells
A detailed breakup and analysis of the cell separation technologies market based on the cell type has also been provided in the report. This includes human and animal cells.
Centrifugation-based Cell Separation
Surface marker-based Cell Separation
Filtration-based Cell Separation
The report has provided a detailed breakup and analysis of the cell separation technologies market based on the technology. This includes centrifugation-based, surface marker-based, and filtration-based cell separation.
Oncology Research
Neuroscience Research
Stem Cell Research
Microbiology
Immunology Research
Others
A detailed breakup and analysis of the cell separation technologies market based on the application have also been provided in the report. This includes oncology research, neuroscience research, stem cell research, microbiology, immunology research, and others.
Research Laboratories and Institute
Biotechnology and Biopharmaceutical Companies
Cell Banks
The report has provided a detailed breakup and analysis of the cell separation technologies market based on the end user. This includes research laboratories and institute, biotechnology and biopharmaceutical companies, and cell banks. According to the report, biotechnology and biopharmaceutical companies represented the largest segment.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cell separation technologies. Some of the factors driving the North America cell separation technologies market included the bolstering growth of the pharmaceutical industry, the rising demand for personalized medicines, and the ongoing advancements in isolation tools.
The report has also provided a comprehensive analysis of the competitive landscape in the global cell separation technologies market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Akadeum Life Sciences, Alfa Laval AB, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Corning Incorporated, Merck KGaA, Miltenyi Biotec Inc., PerkinElmer Inc., pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG, Stemcell Technologies Inc., Terumo Corporation and Thermo Fisher Scientific Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.